Viewing Study NCT04652960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-06-14 @ 7:20 PM
Study NCT ID: NCT04652960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 View
None Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 View
None Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8 View
Keywords: